These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27503678)

  • 1. Ligand-based virtual screen for the discovery of novel M5 inhibitor chemotypes.
    Geanes AR; Cho HP; Nance KD; McGowan KM; Conn PJ; Jones CK; Meiler J; Lindsley CW
    Bioorg Med Chem Lett; 2016 Sep; 26(18):4487-4491. PubMed ID: 27503678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery, synthesis and characterization of a highly muscarinic acetylcholine receptor (mAChR)-selective M5-orthosteric antagonist, VU0488130 (ML381): a novel molecular probe.
    Gentry PR; Kokubo M; Bridges TM; Cho HP; Smith E; Chase P; Hodder PS; Utley TJ; Rajapakse A; Byers F; Niswender CM; Morrison RD; Daniels JS; Wood MR; Conn PJ; Lindsley CW
    ChemMedChem; 2014 Aug; 9(8):1677-82. PubMed ID: 24692176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural modifications to tetrahydropyridine-3-carboxylate esters en route to the discovery of M5-preferring muscarinic receptor orthosteric antagonists.
    Zheng G; Smith AM; Huang X; Subramanian KL; Siripurapu KB; Deaciuc A; Zhan CG; Dwoskin LP
    J Med Chem; 2013 Feb; 56(4):1693-703. PubMed ID: 23379472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of the first M5-selective and CNS penetrant negative allosteric modulator (NAM) of a muscarinic acetylcholine receptor: (S)-9b-(4-chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5(9bH)-one (ML375).
    Gentry PR; Kokubo M; Bridges TM; Kett NR; Harp JM; Cho HP; Smith E; Chase P; Hodder PS; Niswender CM; Daniels JS; Conn PJ; Wood MR; Lindsley CW
    J Med Chem; 2013 Nov; 56(22):9351-5. PubMed ID: 24164599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Muscarinic Acetylcholine Receptor M
    Bender AM; Garrison AT; Lindsley CW
    ACS Chem Neurosci; 2019 Mar; 10(3):1025-1034. PubMed ID: 30280567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Mechanisms of Action of M5 Muscarinic Acetylcholine Receptor Allosteric Modulators.
    Berizzi AE; Gentry PR; Rueda P; Den Hoedt S; Sexton PM; Langmead CJ; Christopoulos A
    Mol Pharmacol; 2016 Oct; 90(4):427-36. PubMed ID: 27461343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic acetylcholine receptor binding affinities of pethidine analogs.
    Lee NR; Zhang X; Darna M; Dwoskin LP; Zheng G
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5032-5. PubMed ID: 26494260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continued optimization of the M
    McGowan KM; Nance KD; Cho HP; Bridges TM; Conn PJ; Jones CK; Lindsley CW
    Bioorg Med Chem Lett; 2017 Mar; 27(6):1356-1359. PubMed ID: 28237763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of M
    Gunter BW; Gould RW; Bubser M; McGowan KM; Lindsley CW; Jones CK
    Addict Biol; 2018 Sep; 23(5):1106-1116. PubMed ID: 29044937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and optimization of 3-(4-aryl/heteroarylsulfonyl)piperazin-1-yl)-6-(piperidin-1-yl)pyridazines as novel, CNS penetrant pan-muscarinic antagonists.
    Bender AM; Weiner RL; Luscombe VB; Ajmera S; Cho HP; Chang S; Zhan X; Rodriguez AL; Niswender CM; Engers DW; Bridges TM; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3576-3581. PubMed ID: 28633897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent binding and functional antagonism by xanomeline at the muscarinic M5 receptor.
    Grant MK; El-Fakahany EE
    J Pharmacol Exp Ther; 2005 Oct; 315(1):313-9. PubMed ID: 16002459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ratiometric Ca+2 measurement in human recombinant muscarinic receptor subtypes using the Flexstation scanning fluorometer.
    Gupta S; Singh RK; Nanda K; Chatterjee M; Tiwari A; Sundaram S; Gupta D; Chugh A; Dastidar S; Ray A
    J Recept Signal Transduct Res; 2009; 29(2):100-6. PubMed ID: 19288301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic agonist, (±)-quinuclidin-3-yl-(4-fluorophenethyl)(phenyl)carbamate: High affinity, but low subtype selectivity for human M
    Lee NR; Gujarathi S; Bommagani S; Siripurapu K; Zheng G; Dwoskin LP
    Bioorg Med Chem Lett; 2019 Feb; 29(3):471-476. PubMed ID: 30554957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic acetylcholine receptor (mAChR) inhibitor from snake venom: interaction with subtypes of human mAChR.
    Miyoshi S; Tu AT
    Arch Biochem Biophys; 1999 Sep; 369(1):114-8. PubMed ID: 10462446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel allosteric effects of amiodarone at the muscarinic M5 receptor.
    Stahl E; Ellis J
    J Pharmacol Exp Ther; 2010 Jul; 334(1):214-22. PubMed ID: 20348203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M2 Subtype preferring dibenzodiazepinone-type muscarinic receptor ligands: Effect of chemical homo-dimerization on orthosteric (and allosteric?) binding.
    Keller M; Tränkle C; She X; Pegoli A; Bernhardt G; Buschauer A; Read RW
    Bioorg Med Chem; 2015 Jul; 23(14):3970-90. PubMed ID: 25650309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatins.
    Bridges TM; Marlo JE; Niswender CM; Jones CK; Jadhav SB; Gentry PR; Plumley HC; Weaver CD; Conn PJ; Lindsley CW
    J Med Chem; 2009 Jun; 52(11):3445-8. PubMed ID: 19438238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of methanthelinium binding and function at human M
    Irmen M; Holze J; Bödefeld T; Tränkle C
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Oct; 391(10):1037-1052. PubMed ID: 29938305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of ether analogues as potent and selective M2 muscarinic receptor antagonists.
    Wang Y; Chackalamannil S; Chang W; Greenlee W; Ruperto V; Duffy RA; McQuade R; Lachowicz JE
    Bioorg Med Chem Lett; 2001 Apr; 11(7):891-4. PubMed ID: 11294385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The optimization of a novel selective antagonist for human M
    Li M; Huang C; Wu X; Ding F; Hu Z; Zhu Y; Zhao L; Hou L; Chen H; Wang H; Xu J; Tang D
    Bioorg Med Chem Lett; 2020 Dec; 30(24):127632. PubMed ID: 33132116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.